Track topics on Twitter Track topics that are important to you
Alteogen Inc. granted Lynkogen Inc. the option to license exclusive global rights (excluding South Korea and emerging markets) to develop and commercialize its GLP-1 mimetic and alpha-1 antitrypsin (A...
Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive option agreement for the development of Alteogen’s novel GLP-1 mimetic a...
China’s Everest licenses global rights to Novartis FGFR4 inhibitor, while Altogen and Lynkogen partner in NASH and metabolic disease.
Alteogen Inc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-dug conjugates, biobetters and b...
We have published hundreds of Lynkogen Inc. news stories on BioPortfolio along with dozens of Lynkogen Inc. Clinical Trials and PubMed Articles about Lynkogen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lynkogen Inc. Companies in our database. You can also find out about relevant Lynkogen Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...